Skip to main content

Tyrvaya News

FDA Approves Tyrvaya (varenicline solution) Nasal Spray for the Treatment of the Signs and Symptoms of Dry Eye Disease

PRINCETON, N.J., Oct. 18, 2021 /PRNewswire/ – Oyster Point Pharma, Inc. (Nasdaq: OYST), today announced that the U.S. Food and Drug Administration (FDA) has approved Tyrvaya (varenicline solution)...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Keratoconjunctivitis Sicca

Tyrvaya patient information at Drugs.com